描述

Prevalence and titers of autoantibodies targeting selenoprotein P in CFS patients versus controls. Elevated autoantibody levels indicate an acquired autoimmune component affecting selenium metabolism.

Figure 2

Chart

Source Paper

Autoantibodies to selenoprotein P in chronic fatigue syndrome suggest selenium transport impairment and acquired resistance to thyroid hormone.

Redox biology (2023)

PMID: 37423160

DOI: 10.1016/j.redox.2023.102796

Cite This Figure

![Figure 2: Prevalence and titers of autoantibodies targeting selenoprotein P in CFS patients versus controls. Elevated autoantibody levels indicate an acquired autoimmune component affecting selenium metabolism.]()

> Source: Qian Sun et al. "Autoantibodies to selenoprotein P in chronic fatigue syndrome suggest selenium t." *Redox biology*, 2023. PMID: [37423160](https://pubmed.ncbi.nlm.nih.gov/37423160/)

<figure>
  <img src="" alt="Prevalence and titers of autoantibodies targeting selenoprotein P in CFS patients versus controls. Elevated autoantibody levels indicate an acquired autoimmune component affecting selenium metabolism." />
  <figcaption>Figure 2. Prevalence and titers of autoantibodies targeting selenoprotein P in CFS patients versus controls. Elevated autoantibody levels indicate an acquired autoimmune component affecting selenium metabolism.<br>  Source: Qian Sun et al. "Autoantibodies to selenoprotein P in chronic fatigue syndrome suggest selenium t." <em>Redox biology</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37423160/">37423160</a></figcaption>
</figure>

描述

Figure 2

Source Paper

Cite This Figure

相关证据